Overview of Dr. Naka
Dr. Yoshifumi Naka is a thoracic surgeon in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Osaka University Medical School and has been in practice 33 years. He is one of 58 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 143 doctors at New York-Presbyterian Hospital who specialize in Thoracic Surgery. He also speaks multiple languages, including Japanese. He has more than 100 publications and over 500 citings.
Office
177 Fort Washington Ave
# 7-435
New York, NY 10032Fax+1 646-426-0156
Education & Training
- Osaka University Medical SchoolClass of 1984
- Osaka UniversityBachelors, Pre-med, 1978 - 1968
Certifications & Licensure
- NY State Medical License 1999 - 2026
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- Top Doctors: New York Metro Area Castle Connolly, 2006-2014
- New York Magazine: Top Doctors Castle Connolly, 2005-2009, 2011-2014
- Join now to see all
Clinical Trials
- Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure Start of enrollment: 2007 Sep 01
- Evaluation of the Safety and Effectiveness of the DuraHeart™ LVAS Start of enrollment: 2008 Jul 01
- Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation Start of enrollment: 2009 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsComparing 3-year survival and readmissions between HeartMate 3 and heart transplant as primary treatment for advanced heart failure.Michael Kirschner, Veli K Topkara, Jocelyn Sun, Paul Kurlansky, Yuji Kaku
The Journal of Thoracic and Cardiovascular Surgery. 2025-01-01 - 1 citationsBridge to simultaneous heart-kidney transplantation via extracorporeal life support: National outcomes in the new heart allocation policy era.Iris Feng, Paul A Kurlansky, Yanling Zhao, Krushang Patel, Morgan K Moroi
The Journal of Heart and Lung Transplantation. 2025-01-01 - Prosthetic Valve Fate in Patients With Continuous-Flow Left Ventricular Assist Devices.Daisuke Kaneyuki, Krushang Patel, Alice V Vinogradsky, Kavya Rajesh, Melissa A Hynds
ASAIO Journal. 2024-11-12
Journal Articles
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019Farhana Latif, Maryjane A Farr, Kevin J Clerkin, Koji Takeda, Yoshifumi Naka, Susan Restaino, Gabriel Sayer, Nir Uriel, JAMA Cardiology
- VA‐ECMO for Cardiogenic Shock in the Contemporary Era of Heart Transplantation: Which Patients Should Be Urgently Transplanted?Yoshifumi Naka, Maryjane A Farr, Koji Takeda, Paolo Colombo, Hiroo Takayama, Arthur R Garan, Veli K Topkara, Clinical Transplantation
- Hypertension: an unstudied potential risk factor for adverse outcomes during continuous flow ventricular assist device supportWasson LT, Yuzefpolskaya M, Wakabayashi M, Takayama H, Naka Y, Uriel N, Jorde UP, Demmer RT, Colombo PC, Heart Fail Rev., 1/1/2015
- Join now to see all
Books/Book Chapters
Authored Content
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
Press Mentions
- NewYork-Presbyterian Expands Heart Transplant and Heart Failure ServicesNovember 1st, 2022
- NewYork-Presbyterian Expands Heart Transplant and Heart Failure ServicesNovember 1st, 2022
- New Data Shows Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure PatientsAugust 29th, 2022
- Join now to see all
Other Languages
- Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: